Grant name: NCI Research Specialist (Clinician Scientist) Award (R50)
Funding organization: National Cancer Institute (NCI)
Total funding amount: Not specified
Duration: Up to 5 years
Primary objective: Support clinician scientists in NCI-funded clinical trials research
Key stakeholders: Clinician scientists, NCI clinical trials networks
Funding source: National Institutes of Health (NIH)
Funding type: Grant
Significance: Supports the continuity of clinician scientists in cancer research
Grant frequency: Recurring
Eligible organization types: Higher Education Institutions, Nonprofits, For-Profit Organizations, Local Governments, Indian/Native American Tribal Governments, Federal Governments, Other specified organizations
Specific qualifications: Clinical degree (M.D., D.O., etc.) and active licensure in oncology
Geographic location: U.S. organizations only; foreign organizations are not eligible
Track record: Must have a record of involvement in NCI-funded clinical trial activities
Organizational structure: Must be affiliated with an academic medical center or community center with NCORP award
Primary focus areas: Cancer treatment, prevention, control, and care delivery clinical trials
Target beneficiaries: Clinician scientists and cancer patients
Expected outcomes: Leadership in clinical trials, development of national clinical trials, and participation in scientific review committees
Technical expertise: Must have significant experience in cancer clinical research
Team composition: Must be a full-time clinician scientist at the institution
Quality standards: Must demonstrate professional accomplishments relevant to NCI mission
Eligible costs: Salary support for 2.4 to 4.8 person-months, travel costs not exceeding $2,500 per year
Ineligible costs: Research expenses must be covered by other sources
Matching fund requirements: Not specified
Application due date: November 5, 2025
Earliest start date: November 4, 2024
Must comply with NIH Grants Policy Statement and federal regulations
No foreign components allowed
Applications must be submitted electronically via Grants.gov
Required documentation includes letters of support and a detailed research plan
Applications must demonstrate a commitment to enhancing recruitment of underrepresented groups in clinical trials
This is a reissue of a previous funding opportunity (PAR-21-306)